Telaprevir News and Research

RSS
Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

Vertex announces availability of INCIVEK to treat hepatitis C in Canada

Vertex announces availability of INCIVEK to treat hepatitis C in Canada

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

AASLD publishes updated practice guidelines on hepatitis C

AASLD publishes updated practice guidelines on hepatitis C

Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

Shorter treatment with telaprevir-based combination regimen may benefit hepatitis C patients

Patients with hepatitis C may benefit from 24 week telaprevir-based regimen

Patients with hepatitis C may benefit from 24 week telaprevir-based regimen

NEJM publishes data from Vertex INCIVEK Phase 3 study on genotype 1 chronic hepatitis C

NEJM publishes data from Vertex INCIVEK Phase 3 study on genotype 1 chronic hepatitis C

Vertex receives Health Canada approval for INCIVEK to treat hepatitis C

Vertex receives Health Canada approval for INCIVEK to treat hepatitis C

Telaprevir drug shows promise in curing hepatitis C infection

Telaprevir drug shows promise in curing hepatitis C infection

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Scarcity of resources calls for equitable distribution system for novel HCV treatment

Scarcity of resources calls for equitable distribution system for novel HCV treatment

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Vertex receives FDA approval for INCIVEK to treat hepatitis C

FDA nod for hepatitis C drug

FDA nod for hepatitis C drug

Innovative detection practices may prevent liver diseases

Innovative detection practices may prevent liver diseases

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

Supreme Court to weigh drug confidentiality laws

Supreme Court to weigh drug confidentiality laws

New data: Quadruple therapy can effectively treat patients with HCV

New data: Quadruple therapy can effectively treat patients with HCV